Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Cipla Ltd ( (IN:CIPLA) ) has shared an update.
Cipla Limited has allotted 1,954 fully paid-up equity shares of INR 2 each following the exercise of employee stock options and stock appreciation rights under its ESOS 2013-A and Cipla ESAR Scheme 2021. As a result of this relatively small issuance, the company’s issued, subscribed and paid-up share capital has marginally increased to INR 1,61,55,65,262, represented by 80,77,82,631 equity shares, signaling ongoing use of equity-based incentives without materially diluting existing shareholders.
More about Cipla Ltd
Cipla Ltd is a Mumbai-based pharmaceutical company that develops and manufactures a wide range of generic drugs and healthcare products. The company focuses on prescription medicines and therapies across multiple therapeutic areas and serves both domestic and international markets.
Average Trading Volume: 127,451
Technical Sentiment Signal: Buy
Current Market Cap: 1035.1B INR
See more insights into CIPLA stock on TipRanks’ Stock Analysis page.